EFMH
HALO icon

E Fund Management (HK)’s Halozyme HALO Stock Holding History

E Fund Management (HK)’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6K Buy
289
+75
+35% +$5.11K 0.01% 292
2026
Q1 		$13.8K Buy
+214
New +$15.1K 0.01% 282

Other funds holding HALO

SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

E Fund Management (HK)'s HALO Position: Q2 2026 in Review

E Fund Management (HK) increased its Halozyme (HALO) stake by 35% in Q2 2026, buying an estimated $5.11K and bringing the position to 289 shares worth $22.6K. The position accounts for 0.01% of the portfolio, ranked #292.

E Fund Management (HK) first reported a position in HALO in Q1 2026 and has held it in 2 quarters since. 207 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • E Fund Management (HK) held 289 shares of Halozyme worth $22.6K as of Q2 2026.
  • E Fund Management (HK) bought 75 Halozyme shares in Q2 2026, an estimated $5.11K.
  • Halozyme made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #292 holding.
  • E Fund Management (HK) first reported a position in Halozyme in Q1 2026 and has held it in 2 quarters since.
  • 207 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.